Recent advances of the pathobiology and treatment of follicular lymphoma and challenging to the new therapeutic avenues

被引：1
作者：
Takata, Katsuyoshi [1 ,2 ]
机构：
[1] Niigata Univ, Dept Mol & Cellular Pathol, Grad Sch Med & Dent Sci, Niigata, Japan
[2] Niigata Univ, Dept Mol & Cellular Pathol, Grad Sch Med & Dent Sci, 1-757,Asahimachi Dori,Chuo Ku, Niigata 9518510, Japan
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY | 2023年 / 63卷 / 04期
关键词：
follicular lymphoma; heterogeneity; tumor microenvironment; BCL2; transformation; TRANSFORMATION;
D O I：
10.3960/jslrt.23051
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：212 / 213
页数：2
相关论文
共 26 条
  • [21] Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma
    Yang, Xiao-Yan
    Lu, Yuan-Fei
    Xu, Jian-Xia
    Du, Yong-Zhong
    Yu, Ri-Sheng
    [J]. MOLECULES, 2023, 28 (03):
  • [22] CAR-T cell therapy in the treatment of relapsed or refractory primary central nervous system lymphoma: recent advances and challenges
    Xiong, Shuzhen
    Zhang, Shuni
    Yue, Ningning
    Cao, Jiajia
    Wu, Chongyang
    [J]. LEUKEMIA & LYMPHOMA, 2025,
  • [23] CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma:: a new case report and review of the literature
    Alvaro-Naranjo, T
    Jaén-Martínez, J
    Gumá-Padró, J
    Bosch-Príncep, R
    Salvadó-Usach, MT
    [J]. ANNALS OF HEMATOLOGY, 2003, 82 (09) : 585 - 588
  • [24] CD20-negative DLBCL transformation after rituximab treatment in follicular lymphoma: a new case report and review of the literature
    T. Álvaro-Naranjo
    J. Jaén-Martínez
    J. Gumá-Padró
    R. Bosch-Príncep
    M. T. Salvadó-Usach
    [J]. Annals of Hematology, 2003, 82 : 585 - 588
  • [25] Consolidation treatment with Yttrium-90 ibritumomab tiuxetan after new induction regimen in patients with intermediate- and high-risk follicular lymphoma according to the follicular lymphoma international prognostic index: a multicenter, prospective phase II trial of the Spanish Lymphoma Oncology Group
    Provencio, Mariano
    Cruz Mora, Miguel A.
    Gomez-Codina, Jose
    Quero Blanco, Cristina
    Llanos, Marta
    Garcia-Arroyo, Francisco R.
    de la Cruz, Luis
    Guma Padro, Josep
    Delgado Perez, Juan R.
    Sanchez, Antonio
    Alvarez Cabellos, Ruth
    Rueda, Antonio
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (01) : 51 - 55
  • [26] Consolidation treatment with yttrium-90 ibritumomab tiuxetan after new induction regimen in advanced stage follicular lymphoma: update results from the Spanish Lymphoma Oncology Group trial after a median follow-up of 8.5-years
    Provencio, Mariano
    Franco, Fernando
    Gomez-Codina, Jose
    Quero Blanco, Cristina
    Llanos, Marta
    Garcia-Arroyo, Francisco
    de la Cruz, Luis
    Guma, Josep
    Ramon Delgado, Juan
    Alvarez, Ruth
    Ignacio Chacon, Jose
    Royuela, Ana
    Rueda, Antonio
    [J]. LEUKEMIA & LYMPHOMA, 2019, 60 (03) : 856 - 859
123